Skip to content

The effect of Phenalis oral capsules on sexual function and satisfaction in postmenopausal women.

Study and comparison of the effect of a combined oral capsule containing lemon balm and fennel on sexual function and sexual satisfaction in postmenopausal women

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250417065363N1
Enrollment
88
Registered
2025-05-15
Start date
2025-05-05
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual function and sexual satisfaction.

Interventions

Intervention 1: Intervention group: Oral capsule containing fennel and lemon balm. Manufactured by the Traditional Medicine and Medical Supplies Research Center of Shahid Beheshti University of Medica

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to No maximum

Inclusion criteria

Inclusion criteria: Be Iranian. Must be at least literate. Not have hearing, speech, or mental disorders that prevent communication with the researcher. At least one year has passed since their menstruation stopped. Do not use herbal teas while taking the medication. Not wanting or needing to use hormone replacement therapy. she doesnt use chemical or herbal medicine for their treatment. Postmenopausal women and their partners should be sexually active. The husband of a menopausal woman, according to her statements, does not have sexual dysfunction (erectile dysfunction, ejaculation). she has not undergone hysterectomy, oophorectomy, cystocele, rectocele, or mastectomy. Postmenopausal women and their spouses (self-reported spouses) should not have a known mental illness. Not be addicted to cigarettes or drugs. Have not recently used antidepressants or anti-anxiety medications. They should not have a history of known chronic diseases such as diabetes, high blood pressure, asthma, immune system disorders, etc. There should be no specific event or incident that constitutes a crisis in their lives, such as the death of a loved one, a terminal illness in a family member, or a change of residence. Have no history of allergy to medicinal plants.

Exclusion criteria

Exclusion criteria: Possible side effects of the capsules Unwillingness to continue treatment, such as stopping taking the capsule for 3 consecutive days or a non-consecutive week.

Design outcomes

Primary

MeasureTime frame
Sexual function score in Female Sexual Function Index questionnaire. Timepoint: At the beginning of the study, 2 and 3 months after the end of the intervention. Method of measurement: Women's Sexual Function Index Questionnaire.;Sexual satisfaction score on the Larson Sexual Satisfaction Questionnaire. Timepoint: At the beginning of the study, 2 and 3 months after the end of the intervention. Method of measurement: Larson Sexual Satisfaction Questionnaire(LSSQ).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShamim Naghibinezhad

Shahid Beheshti University of Medical Sciences

sh.naghibinezhad@sbmu.ac.ir+98 21 2670 2259

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026